Immuron Presentation Australian Biologics Festival 2024

Rhea-AI Summary

Immuron Limited announces the participation of their Research & Development Manager at the Australian Biologics Festival 2024, showcasing their innovative work in biopharmaceuticals.

MELBOURNE, Australia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Research & Development Manager, Joanne Casey, PhD will be presenting at the Australian Biologics Festival 2024 on Wednesday, 21^st February in Melbourne, Australia.

A copy of the presentation slide deck is available on the Company’s website.

https://www.immuron.com.au/corporate-presentations/

Authorised for release by the Board of Immuron Limited.

COMPANY CONTACT: Steven Lydeamore Chief Executive Officer Ph: +61 (0)3 9824 5254 info@immuron.com

About Immuron
Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of infectious diseases.

For more information visit: http://www.immuron.com

FAQ

When is Joanne Casey, PhD presenting at the Australian Biologics Festival 2024?

Joanne Casey, PhD will be presenting at the Australian Biologics Festival 2024 on Wednesday, 21st February.

Where is the Australian Biologics Festival 2024 taking place?

The Australian Biologics Festival 2024 is taking place in Melbourne, Australia.

Where can the presentation slide deck be accessed?

The presentation slide deck can be accessed on Immuron Limited's website at https://www.immuron.com.au/corporate-presentations/